Trials / Completed
CompletedNCT04649502
Metformin for the Treatment of Hidradenitis Suppurativa (HS)
Rediscovery of Metformin for the Chronic Disabling Auto-inflammatory Disease Hidradenitis Suppurativa
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 62 (actual)
- Sponsor
- K.R. van Straalen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A randomized controlled trial investigating the metformin is the treatment for hidradenitis suppurativa. Metformin combined with doxycycline will be compared to the standard treatment of doxycycline monotherapy for HS severity and the effect on the pre-diabetic condition.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Metformin | Metformin in combination with doxycycline |
Timeline
- Start date
- 2021-01-25
- Primary completion
- 2023-01-29
- Completion
- 2023-08-23
- First posted
- 2020-12-02
- Last updated
- 2023-10-11
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT04649502. Inclusion in this directory is not an endorsement.